Xarelto is the first once-a-day blood thinner, or anticoagulant, approved by the FDA. Unlike its predecessor, Warfarin, it does not require dosage and diet monitoring and comes in a convenient once-a-day pill. Early on, studies showed problems with the drug possibly leading to internal bleeding. Bayer chose not to label the packaging with a warning. In the first year, over 2,000 “Serious Adverse Event” reports were filed with the FDA and of those, 151 were deaths. Since then about 7 million people worldwide have been prescribed Xarelto. Take a closer look at the infographic outlining the history of the Xarelto lawsuit and to learn more, watch the Xarelto State of the Claim video here.